Triumeq 5 mg/60 mg/30 mg dispersible tablets
*Company:
ViiV Healthcare BVStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 23 October 2025
File name
ie-spc-triumeq5mg-issue7draft1-clean-noheaders.pdf
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Section 4.6 (sentence added regarding occurrence of transfer)
Section 4.8 (Table 4 updated with the frequency of transfer, footer also updated)
Section 10 (date updated)
Updated on 28 February 2025
File name
ieukni-spc-triumeq-dispersible-issue6draft1-no headers.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 28 February 2025
File name
ie-pl-triumeq-dispersible-issue6draft1-no headers.pdf
Reasons for updating
- New PIL for new product
ViiV Healthcare BV
Address:
12 Riverwalk, Citywest Business Campus, Dublin 24, IrelandTelephone:
+353 1 495 5000Medical Information Direct Line:
1 800 244 255